A Clinical Investigation of the C2a-Taper™ Acetabular System

Completed

Conditions studied: Osteoarthritis, Avascular Necrosis, Congenital Hip Dysplasia, Traumatic Arthritis

In brief

The objective of this study is to gather clinical and survivorship information for the C2a-Taper™ Acetabular System, a ceramic-on-ceramic hip articulating system.

Key facts

Study ID

NCT00578851

Run by

Biomet Orthopedics, LLC

People needed

28

Starts

2006-04-01

Expected to finish

2015-10-01

Last updated by the study team

2017-06-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Skeletally mature patients with non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and traumatic arthritis

You may not qualify if…

• Patients with: Osteoporosis, metabolic disorders, osteomalacia, rapid joint destruction, vascular insufficiency, muscular atrophy, and neuromuscular disease

Where it is running

• Physician's Clinic of Iowa, PCI — Cedar Rapids, Iowa, United States
• Lexington Clinic — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.